SCHEMBL29471198

SCHEMBL29471198

Cc1cc2c(N3CCN(C)c4cc(-c5cnn(C)c5)ccc43)cc(OCC(=O)OC(C)(C)C)cc2n(C)c1=O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.38
▸ DYRK1A Q13627 4/20 0.38
▸ WNT1 P04628 1/20 0.38
▸ LRRK2 Q5S007 1/20 0.36
▸ RET P07949 4/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ CREBBP Q92793 3/20 0.34
▸ PRMT5 O14744 1/20 0.33
▸ WDR77 Q9BQA1 1/20 0.33
▸ TTK P33981 1/20 0.33
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33
▸ PSENEN Q9NZ42 1/20 0.33
▸ GPR119 Q8TDV5 1/20 0.32
▸ MET P08581 2/20 0.32
▸ USP30 Q70CQ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26548496 1.00 GSK3B (0.38) GSK3BDYRK1AWNT1LRRK2RET
SCHEMBL29471161 0.90 BRD4 (0.37) GSK3BDYRK1AWNT1LRRK2BRD4
SCHEMBL24316676 0.90 BRD4 (0.37) GSK3BDYRK1AWNT1LRRK2BRD4
SCHEMBL29471148 0.87 CREBBP (0.37) GSK3BDYRK1AWNT1BRD4CREBBP
SCHEMBL24316675 0.87 CREBBP (0.37) GSK3BDYRK1AWNT1BRD4CREBBP
SCHEMBL24316581 0.86 RET (0.36) RETCREBBPPRMT5WDR77USP30
SCHEMBL29471251 0.86 RET (0.36) RETCREBBPPRMT5WDR77USP30
SCHEMBL29471289 0.83 RET (0.36) RETCREBBPPRMT5WDR77USP30
SCHEMBL24316610 0.80 FGFR1 (0.40) LRRK2BRD4CREBBPMET
SCHEMBL29471262 0.80 MAPT (0.37) BRD4PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4210683-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS Aurigene Oncology Limited (IN) 2023-07-19 — — EP disclosed
WO-2022053967-A1 HETEROCYCLIC COMPOUNDS AS CBP/EP300 BROMODOMAIN INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2022-03-17 — — WO disclosed
Send feedback